Overview
- 44 inspections across 43 sites are on record.
- 111 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-09-15.
At a glance
Inspections
44
Sites
43
Observations
111
Career since
Sep 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cleveland Cord Blood Center | 15 Sep 2023 | Biologics | View 483 → |
| University of Texas MD Anderson Cancer Center | 24 Mar 2022 | Biologics | View 483 → |
| Grifols Diagnostic Solutions, INC. | 17 Feb 2022 | Biologics | View 483 → |
| SAFC Carlsbad Inc. | 16 Dec 2021 | Biologics | On file |
| Par Health USA, LLC | 22 Oct 2021 | Biologics | On file |
Sites inspected
Cleveland Cord Blood CenterWarrensville Heights, United States1 insp.
University of Texas MD Anderson Cancer CenterHouston, United States1 insp.
Grifols Diagnostic Solutions, INC.San Diego, United States1 insp.
SAFC Carlsbad Inc.Carlsbad, United States1 insp.
Par Health USA, LLCRochester, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Elmina E Akwo4 shared
Steven E Bowen3 shared
Scott T Ballard3 shared
Linda Thai2 shared
Gene D Arcy2 shared
Susan M Jackson2 shared
Kanaeko R Ravenell2 shared
Nancy L Neiger1 shared
Darla J Christopher1 shared
Richard L Bartlett1 shared
Full investigator report
Get the verbatim findings behind Lauren M Lilly's 111 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site